Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
652
Employees652
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
652
Employees652

SUPN Key Statistics

Market cap
1.93B
Market cap1.93B
Price-Earnings ratio
1.37K
Price-Earnings ratio1.37K
Dividend yield
Dividend yield
Average volume
511.78K
Average volume511.78K
High today
$34.38
High today$34.38
Low today
$33.47
Low today$33.47
Open price
$33.84
Open price$33.84
Volume
97.58K
Volume97.58K
52 Week high
$39.09
52 Week high$39.09
52 Week low
$21.99
52 Week low$21.99
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.